Introduction & Hook
- AI disruption fears triggered a brutal selloff with the S&P 500 closing down 1.0% at 6,850 (below its 50-day MA), Nasdaq dropping 1.1%, Dow tumbling 1.7%, and Russell 2000 falling 1.6% as software names imploded on automation concerns.
- The market’s technical breakdown below key support levels, combined with extremely bearish breadth (558 bears vs 124 bulls on the 4% metric), suggests last week’s rally was merely a dead-cat bounce rather than a genuine sentiment shift.
Today’s Scorecard — What Worked & What Didn’t
- Defensive sectors dominated: Consumer Staples surged 1.5% led by Walmart (WMT +2.29% to $125.81), Healthcare gained 1.2% with Eli Lilly (LLY +4.86% to $1,058.56) benefiting from Novo Nordisk’s drug trial disappointment (NVO -16.43%), and Utilities added 0.7% as investors fled risk assets.
- Mining and precious metals shined: Energy held up relatively well at 3.53 ATR (84th percentile), while Mining sector posted 2.31 ATR with standouts including Agnico Eagle (AEM +5.4% to $240.49) and Fortuna Silver (FSM +8.7% to $13.34) as gold surged $146 to $5,226.
- Software carnage intensified: The iShares Software ETF plunged 4.7% as AI disruption fears crushed names like Datadog (DDOG -11.28% to $102.62), CrowdStrike (CRWD -9.85% to $350.33), and IBM (IBM -13.13% to $223.38) on Claude’s COBOL automation news.
- Market breadth catastrophic: Only 42% of stocks above their 20-day MA, sentiment at 4% Very Bearish reading with 124 bulls vs 558 bears, while Finance sector hit historic lows at -2.16 ATR (0th percentile) dragged down by asset managers KKR (-8.89%) and payment processors like American Express (AXP -7.20%).
Key Earnings & Economic Calendar
- RingCentral (RNG) beat-and-raise crushed: Despite posting 20% EPS growth to $1.18, expanding margins to 22.8%, and record Q4 free cash flow of $126M, the stock plummeted 12.5% to $34.58 as investors dumped anything tech-related in today’s AI-fear driven selloff.
- Novo Nordisk (NVO) weight-loss drug miss: Competitor’s weaker results for its newest obesity treatment sent NVO down 16.43% to $39.63 while gifting Eli Lilly a 4.86% rally as the clear winner in the GLP-1 space.
- Tomorrow’s economic data light: Factory orders data showed -0.7% decline in December (vs 0.9% consensus), but ex-transportation orders rose 0.4%, indicating weakness concentrated in one sector rather than broad-based deterioration.
- Tomorrow’s calendar quiet: No major economic releases or earnings scheduled for Tuesday, putting focus squarely on tariff uncertainty after President Trump raised Section 122 tariffs to 15% from 10% and late reports suggest Congress unlikely to extend beyond 150 days.
Tomorrow’s Watchlist & Setups
- FSM at $13.34 — D9M and 9M Catalyst signal, mining stock breaking out with 8.7% gain on 1.6x volume, next resistance at $14.50 with stop under $12.80 (4.7% risk), riding precious metals momentum as gold hits new highs.
- ACLX at $113.75 — 9M Catalyst explosive move up 77.4% on 43.5x volume, biotech episodic pivot after catalyst, now extended but watch for consolidation near $110-$115 zone for potential continuation setup in coming days.
- LLY at $1,058.56 — Healthcare leader benefiting from competitor weakness, cleared $1,040 resistance with conviction on strong volume, continuation pattern forming with potential run toward $1,100 psychological level, stop under $1,030.
- AEM at $240.49 — 2LYNCH continuation signal in mining sector, gold miner up 5.4% with strong institutional support, consolidating near highs with $245-$250 next target zone, defensive play in risk-off environment.
- Focus on defensive healthcare and precious metals: Medical sector at -0.16 ATR showing relative strength vs market, Mining at 2.31 ATR trending higher, avoid Finance (-2.16 ATR at 0th percentile), Retail (-0.60 ATR at 0th percentile), and all software exposure.
Strategy Outlook & Scenarios
- Bullish scenario requires major repair work: S&P 500 must reclaim the 6,896 level (50-day MA) on expanding volume with breadth improving above 50% of stocks over 20-day MA and defensive rotation reversing—none of which appears likely in the near term given tariff uncertainty and AI disruption narrative gaining steam.
- Bearish scenario already unfolding: Break below 6,850 support opens door to 6,720-6,750 zone (200-day MA area), accelerated selling in software/tech confirmed by Finance sector at record lows signals institutional capitulation, Bitcoin breaking $65K adds to risk-asset contagion fears.
- Strategy signals flashing caution with selective opportunities: 2LYNCH generated 69 signals (down from previous sessions), D9M at 108 (mining-heavy), Reversal Bullish showing 153 but mostly low-quality, Darvas Box 352 signals (many false breakouts likely), focus on 9M Catalyst’s 15 high-conviction episodic pivots for aggressive plays.
- Action codes: ABC + BTFD (selectively): Always Be in Control means reducing exposure and taking profits on any strength, while Buy The Dip only applies to proven defensive sectors (healthcare, staples, utilities) and precious metals—avoid catching falling knives in software, payments, or asset managers until capitulation signals emerge.
Summary & Final Thoughts
- Tomorrow’s game plan: Trade defensively with focus on healthcare leaders like LLY, precious metals momentum in FSM/AEM, and wait for high-probability episodic pivots in beaten-down quality names rather than trying to call a bottom in the wreckage of software and financials.
- Key risk to manage: Tariff uncertainty escalating after EU paused trade deal approval and Congress likely won’t extend Section 122 beyond 150 days creates policy vacuum that could trigger further institutional selling, especially in consumer discretionary and anything with overseas manufacturing exposure.
- Overall market stance: DEFENSIVE with selective offensive strikes: Reduce portfolio exposure to 30-40% invested, focus capital on proven defensive sectors showing relative strength, use tight 3-5% stops on any new positions, and reserve 60-70% cash for better risk/reward setups after this selling wave exhausts itself—market needs to prove itself, not the other way around.